Search

Your search keyword '"J. Muhlestein"' showing total 7 results
Start Over Author "J. Muhlestein" Publisher elsevier bv
7 results on '"J. Muhlestein"'

1. MULTIVESSEL VERSUS CULPRIT-ONLY PCI IN PATIENTS WITH NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL DISEASE: RESULTS FROM THE PROMETHEUS STUDY

Author

Timothy Henry, Stuart Keller, Birgit Vogel, William S. Weintraub, Sandra Weiss, Jaya Chandrasekhar, Serdar Farhan, Stuart J. Pocock, Anthony C. DeFranco, Brian A. Baker, Samantha Sartori, Sunil V. Rao, Samir Kapadia, Catalin Toma, Sabato Sorrentino, Roxana Mehran, J. Muhlestein, Annapoorna Kini, Usman Baber, Craig Strauss, Michela Faggioni, and Mark B. Effron

Subjects
medicine.medical_specialty, business.industry, medicine.medical_treatment, Multivessel disease, medicine.disease, Revascularization, Culprit, Internal medicine, Conventional PCI, medicine, Cardiology, ST segment, Observational study, In patient, cardiovascular diseases, Myocardial infarction, Cardiology and Cardiovascular Medicine, business
Abstract

Background: Multivessel (MV) disease is present in a significant number of patients with non-ST-segment elevation myocardial infarction (NSTEMI). The optimal revascularization strategy in these patients is uncertain. Methods: PROMETHEUS was a multicenter observational study of patients undergoing

Published
2017
Full Text
View/download PDF

2. USE OF POTENT P2Y12 INHIBITORS IN AFRICAN-AMERICAN PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES

Author

Birgit Vogel, William Weintraub, Sandra Weiss, Mark B. Effron, J. Muhlestein, Stuart Keller, Brian Baker, Michela Faggioni, Clayton Snyder, Sunil Rao, Jaya Chandrasekhar, Melissa Aquino, Catalin Toma, Samantha Sartori, Stuart Pocock, Timothy D. Henry, Craig Strauss, Samir Kapadia, Roxana Mehran, Anthony DeFranco, Usman Baber, and Annapoorna Kini

Subjects
African american, medicine.medical_specialty, Acute coronary syndrome, Prasugrel, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, 030204 cardiovascular system & hematology, medicine.disease, Clopidogrel, 03 medical and health sciences, 0302 clinical medicine, P2Y12, Internal medicine, Conventional PCI, Medicine, cardiovascular diseases, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, Cardiovascular outcomes, medicine.drug
Abstract

Background: African American (AA) patients are at high risk for adverse cardiovascular outcomes after PCI, thus providing a rationale for use of potent P2Y12 inhibitors in such individuals. However, whether or not race is a determinant of prasugrel versus clopidogrel use in acute coronary syndrome (

Published
2017
Full Text
View/download PDF

3. WAIST CIRCUMFERENCE IS A STRONG PREDICTOR OF REGIONAL LEFT VENTRICULAR DYSFUNCTION IN ASYMPTOMATIC DIABETIC PATIENTS: THE FACTOR- 64 STUDY

Author

Boaz D. Rosen, Joao A.C. Lima, Jeffrey G. Anderson, Ravi K. Sharma, Yitzhak Rosen, Kenneth D. Horton, Donald L Lappe, J. Muhlestein, and Heidi May

Subjects
medicine.medical_specialty, Waist, business.industry, medicine.disease, Circumference, Obesity, Asymptomatic, Surgery, Coronary artery disease, Heart failure, Internal medicine, Cardiology, Medicine, cardiovascular diseases, medicine.symptom, Metabolic syndrome, Cardiology and Cardiovascular Medicine, business, Abdominal obesity
Abstract

Obesity is major health problem. Abdominal obesity is associated with the metabolic syndrome, coronary artery disease (CAD) and heart failure (HF). It is unclear if abdominal obesity is associated with left ventricular (LV) dysfunction independently of hypertension (HTN), CAD and weight among

Published
2016
Full Text
View/download PDF

4. PREDICTORS OF 1 YEAR NET ADVERSE CARDIOVASCULAR EVENTS (NACE) AMONG ACS PATIENTS UNDERGOING PCI WITH CLOPIDOGREL OR PRASUGREL: ANALYSIS FROM THE PROMETHEUS REGISTRY

Author

Brian Baker, J. Muhlestein, Samir R. Kapadia, Siddharth A. Wayangankar, Annapoorna Kini, Catalin Toma, Timothy D. Henry, Stuart Keller, Sandra Weiss, Samantha Sartori, Anthony C. DeFranco, Roxana Mehran, Mark B. Effron, William S. Weintraub, Usman Baber, Kanhaiya L. Poddar, Sunil V. Rao, and Craig Strauss

Subjects
medicine.medical_specialty, Prasugrel, business.industry, 030204 cardiovascular system & hematology, Clopidogrel, Surgery, 03 medical and health sciences, 0302 clinical medicine, Conventional PCI, Emergency medicine, medicine, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, medicine.drug
Published
2016
Full Text
View/download PDF

5. USE OF CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FACTORS INFLUENCING REAL-WORLD THERAPEUTIC DECISION-MAKING

Author

Samir Kapadia, Anthony C. DeFranco, Timothy Henry, Sandra Weiss, Samantha Sartori, Stuart J. Pocock, Roxana Mehran, Melissa Aquino, Annapoorna Kini, Stuart Keller, Brian A. Baker, Jaya Chandrasekhar, William S. Weintraub, Usman Baber, J. Muhlestein, Catalin Toma, Mark B. Effron, Olga Salianski, Sunil V. Rao, and Kanhaiya L. Poddar

Subjects
medicine.medical_specialty, Acute coronary syndrome, Prasugrel, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, Therapeutic decision making, Platelet inhibition, Clopidogrel, medicine.disease, Internal medicine, Conventional PCI, Cardiology, Medicine, In patient, cardiovascular diseases, Cardiology and Cardiovascular Medicine, business, medicine.drug
Abstract

The determinants of clinical decision-making for potent platelet inhibition with prasugrel versus clopidogrel in real-world patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) remain poorly characterized. The purpose of this study was to identify factors

Published
2016
Full Text
View/download PDF

6. INCIDENCE, PREDICTORS AND IMPACT OF STROKE AFTER PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES: RESULTS FROM THE PROMETHEUS REGISTRY

Author

Stuart J. Pocock, Kanhaiya L. Poddar, Samantha Sartori, Usman Baber, Mark B. Effron, Samir Kapadia, Gennaro Giustino, J. Muhlestein, Timothy Henry, Brian A. Baker, Stuart Keller, Melissa Aquino, Sandra Weiss, Roxana Mehran, Jaya Chandrasekhar, Catalin Toma, Sunil V. Rao, Shunsuke Aoi, Anthony C. DeFranco, and William S. Weintraub

Subjects
medicine.medical_specialty, business.industry, Incidence (epidemiology), medicine.medical_treatment, Conventional PCI, medicine, Percutaneous coronary intervention, cardiovascular diseases, Cardiology and Cardiovascular Medicine, Intensive care medicine, medicine.disease, business, Stroke
Abstract

The contemporary incidence, associated factors and implications of stroke after acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI) and novel antiplatelet drugs is unknown. We sought to characterize the incidence, predictors and impact of stroke on subsequent

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results